Stocks from India: ranking by score
MeridIAn analyzes 10 companies from India across 6 sectors. Their average score is 6.0 out of 10, above the whole ranking (5.8). The best scored right now are Tata Consultancy Services (6.9), Infosys (6.6) and Sun Pharmaceutical Industries (6.6). Half of them trade below a P/E of 16.6 and the median yield among dividend payers is 1.6%. By sector, the largest groups are Technology (3) and Financial Services (2).
All 10, by score
| # | Company | Sector | Score | P/E | Div. | Market cap |
|---|---|---|---|---|---|---|
| 1 | Tata Consultancy ServicesTCS.NS | Technology | 6.9 | 15.7 | 3.0% | $81.0B |
| 2 | InfosysINFY | Technology | 6.6 | 13.2 | 4.9% | $43.3B |
| 3 | Sun Pharmaceutical IndustriesSUNPHARMA.NS | Healthcare | 6.6 | 34.9 | 0.9% | $43.9B |
| 4 | Bharti AirtelBHARTIARTL.NS | Communication Services | 6.4 | 37.7 | 1.3% | $117.0B |
| 5 | ITCITC.NS | Consumer Defensive | 6.2 | 16.8 | 6.0% | $34.6B |
| 6 | WiproWIT | Technology | 6.2 | 11.9 | 5.4% | $16.5B |
| 7 | HDFC BankHDB | Financial Services | 5.9 | 14.2 | 1.9% | $113.1B |
| 8 | ICICI BankIBN | Financial Services | 5.8 | 16.3 | 0.9% | $100.1B |
| 9 | Reliance IndustriesRELIANCE.NS | Energy | 4.9 | 21.2 | 0.5% | $164.5B |
| 10 | Dr. Reddy's LaboratoriesRDY | Healthcare | 4.0 | 27.7 | 0.7% | $10.2B |
Where it stands out
It scores better than the whole ranking on quality / moat (8.0 vs 5.9) and financial health (7.7 vs 6.2), and worse on momentum (2.2 vs 6.0) and growth (6.1 vs 6.6).
| Category | India | Whole ranking |
|---|---|---|
| Financial health | 7.7 | 6.2 |
| Quality / Moat | 8.0 | 5.9 |
| Valuation | 5.2 | 5.3 |
| Growth | 6.1 | 6.6 |
| Dividend | 5.5 | 4.9 |
| Momentum | 2.2 | 6.0 |
| Risk & Context | 6.4 | 6.4 |
Median of each category (0 to 10)
Highest dividend yields
By sector
Other countries
Other screeners
The score sums up, from 0 to 10, what the analysis says about each company; each company page explains it category by category. What does each figure mean? Metrics glossary →
General information for educational purposes, not investment advice. Figures from the latest weekly analysis (Oct 8, 2026) with the latest available price.